Vabysmo

Traffic light go start restart green light

Pharma

After 3 CRLs, FDA approves Outlook's AMD drug Lytenava

The FDA has approved Outlook's Lytenava for wet age-related macular degeneration. The compound has been used off-label in the indication for two decades.

Kevin Dunleavy Jul 27, 2026 11:51am

Roches headquarters in Basel sunset in the background

Roche defends 6B franc Vabysmo peak target despite another miss

Jul 23, 2026 11:32am

Regeneron sees more regulatory issues, sales declines for Eylea

Apr 29, 2026 12:05pm

Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Ligand lays out $739M for royalty aggregator compatriot Xoma

Apr 27, 2026 10:19am

UPDATED: Roche Q1 earnings see hits and misses across key products

Apr 24, 2026 1:55pm

Genentech taps Damon Wayans for ‘All Eyes on DME’ campaign

Apr 24, 2026 8:57am